US Patent

US10016504 — Compositions

Formulation · Assigned to Norgine BV · Expires 2033-09-10 · 7y remaining

Vulnerability score 25/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects compositions and methods for preparing solutions associated with Infuvite Adult.

USPTO Abstract

The invention also provides methods and kits associated with, or making use of the solutions, and compositions for the preparation of the solutions.

Drugs covered by this patent

Infuvite Adult (ASCORBIC ACID)

Patent Metadata

Patent number: US10016504
Jurisdiction: US
Classification: Formulation
Expires: 2033-09-10
Drug substance claim: No
Drug product claim: Yes
Assignee: Norgine BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.